Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas

Cancer

Volumn 78, Issue 9, 1996, Pages 1929-1934

  Tsukamoto, Kazuhiro ^a   Ito, Noriko ^a   Yoshimoto, Masataka ^b   Iwase, Takuji ^b   Tada, Takashi ^b   Kasumi, Fujio ^b   Nakamura, Yusuke ^c   Emi, Mitsuru ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

BRCA2; breast carcinoma; chromosome 13q; loss of heterozygosity; progesterone receptor; retinoblastoma; tumor suppressor gene

Indexed keywords

PROGESTERONE RECEPTOR;

ALLELE; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME 13Q; CHROMOSOME ANALYSIS; FEMALE; GENE ACTIVATION; GENE DELETION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029805835     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19961101)78:9<1929::aid-cncr13>3.0.co;2-%23     Document Type: Article

References (28)

1. Devilee P, van den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL, et al. At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 1989;5:554-60.
2. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura, Y. Accumulation of genetic alterations and progression of primary breast cancer, Cancer Res 1991;51:5794-9.
3. Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM, et al. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosom Cancer 1992;4:113-21.
4. Deng G, Chen L-C, Schott DR, Thor A, Bhargava V, Ljung B-M, et al. Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 1994;54:499-505.
5. Hill SM, Rodgers CS, Hulten MA. Cytogenetic analysis in human breast carcinoma. II. Seven cases in the triploid/ tetraploid range investigated using direct preparations. Cancer Genet Cytogenet 1987;24:45-62.
6. Dutrillaux B, Gerbault-Seureau M, Zafrani B. Characterization of chromosomal anomalies in human breast cancer. Cancer Genet Cytogenet 1990;49:203-17.
7. Lundberg C, Skoog L, Cavenee WK, Nordenskjöld M. Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. Proc Natl Acad Sci USA 1987;84:2372-6.
8. Kerangueven F, Allione F, Noguchi T, Adélaïde J, Sobol H, Jacquemier J, et al. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors. Genes Chromosom Cancer 1995;13:291-4.
9. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani SR, et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995;10:1673-5.
10. Cleton-Jansen A-M, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ, et al. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 1995;72:1241-4.
11. T'Ang A, Varley JM, Chakraborty S, Murphree L, Fung Y-KT. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988;242:263-6.
12. Varley MJ, Armour J, Swallow JE, Jeffreys AJ, Ponder BAJ T'Ang A, et al. The retinoblastoma gene is frequently altered leading to loss of expression in primary breast tumours. Oncogene 1989;4:725-9.
13. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265:2088-90.
14. Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 1990;50:7184-9.
15. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, et al. The 1993-94 Généthon human genetic linkage map. Nat Genet 1994;7:246-339.
16. Japanese Breast Cancer Society. The general rules for clinical and pathological recording of breast cancer. Jpn Surg 1989;19:612-32.
17. Harbour JW, Lai S-L, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988;241:353-7.
18. Toguchida J, Ishizaki K, Sasaki MS, Nakamura Y, Ikenaga M, Kato M, et al. Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma. Nature 1989;338:156-8.
19. Ishikawa J, Xu H-J, Hu S-X, Yandell DW, Maeda S, Kamidono S, et al. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 1991;51:5736-43.
20. Cliby W, Ritland S, Hartmann L, Dodson M, Hailing KC, Keeney G, et al. Human epithelial ovarian cancer allelotype. Cancer Res 1993;53:2393-8.
21. Dodson MK, Cliby WA, Xu H-J, DeLacey KA, Hu S-X, Keeney GL, et al. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus. Cancer Res 1994;54:610-3.
22. Yoo GH, Xu H-J, Brennan JA, Westra W, Hruban RH, Koch W, et al. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 1994;54:4603-6.
23. Pei L, Melmed S, Scheithauer B, Kovacs K, Benedict WF, Prager D. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 1995;55:1613-6.
24. Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer 1995;72:383-5.
25. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
26. Harada Y, Katagiri T, Ito I, Akiyama F, Sakamoto G, Kasumi F, et al. Genetic studies of 457 breast cancers: clinicopathologic parameters compared with genetic alterations. Cancer 1994;74:2281-6.
27. Ito I, Yoshimoto M, Iwase T, Watanabe S, Katagiri T, Harada Y, et al. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer 1995;71:438-41.
28. Horwitz KB. Mechanisms of hormone resistance in breast cancer. Breast Cancer Res Treat 1993;26:119-30.